Key points Venous thromboembolism (VTE) in pregnancy remains a leading cause of direct
maternal mortality in the developed world and identifiable risk factors are increasing in …

Key Clinical Points Venous Thrombosis in Pregnancy Venous thromboembolism is a
leading cause of maternal mortality and morbidity in the developed world. The risk of deep …

Preeclampsia (PE) is a complex, multisystem disorder that remains a leading cause of
morbidity and mortality in pregnancy. Four main classes of dysregulation accompany PE …

One to 2 pregnant women in 1000 will experience venous thromboembolism (VTE) during
pregnancy or postpartum. Pulmonary embolism (PE) is a leading cause of maternal …

Introduction Pregnancy is a well-established risk factor for venous thromboembolism, and is
associated with a state of hypercoagulability or parameters of thrombin generation …

Problem To examine whether the level of plasma D‐dimer can guide anticoagulant
treatment in recurrent pregnancy loss (RPL) associated with antiphospholipid syndrome …

D-Dimer (DD) is the smallest fragment of plasmin-mediated cleavage of fibrin. There is a
progressive increase in DD concentration with advancing gestation in normal pregnancies …

Background: Gestational age-specific reference values are essential for the accurate
interpretation of haemostatic tests during pregnancy. Methods: Our 1-year prospective study …

Pregnancy and the postpartum period substantially increase the risk for thrombotic events.
Although the absolute risk for thrombosis is low, these events comprise a significant portion …

Pregnancy and the postpartum period are associated with an increased risk of venous
thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a …